<p><strong><u>ACNE IN VULGARIS</u></strong></p><p>Acne vulgaris (pimples or spots) is a common chronic inflammatory skin disorder involving the hair follicle and sebaceous gland which presents mainly in adolescence. A variety of spots appear mostly on the face and other parts of the body. Severe&nbsp; acne may&nbsp; require&nbsp;evaluation to exclude an underlying hormonal disorder. This condition may induce some psychological disturbances. The choice of treatment depends on age, severity, and whether the acne is predominantly inflammatory or comedonal.</p><p><strong>CAUSES</strong></p><ul><li>Increased sebum secretion</li><li>Abnormal keratinisation of the hair follicles (hereditary)</li><li>Increased sensitivity of the sebaceous glands to male hormones</li><li><i>Propionibacterium acne</i>s</li><li>Prolonged use of systemic and topical steroids e.g. Anabolic steroids such as danazol, stanozolol and nandrolone</li><li>Use of pomades, especially products that contain lanolin, petrolatum, vegetable oils, butyl stearate, lauryl alcohol and oleic acid</li><li>Contraceptive agents: medroxyprogesterone injection, implanted or intrauterine progesterone, and oral contraceptives</li><li>Pregnancy</li><li>Polycystic ovarian syndrome</li><li>Adrenal disorders</li></ul><p>&nbsp;</p><p><strong>SYMPTOMS</strong></p><ul><li>Pimples (on the face and occasionally on the trunk, chest and shoulders)</li><li>Greasy skin</li><li>Facial disfigurement</li></ul><p><strong>SIGNS</strong></p><ul><li>Comedones (blackheads and whiteheads)</li><li>Papules</li><li>Cysts</li><li>Scars</li><li>Nodules</li><li>Pustules</li><li>Hirsutism (suggest excess androgens)</li></ul><p>&nbsp;</p><p><strong>INVESTIGATIONS</strong></p><ul><li>Usually none</li><li>Serum testosterone (in females with accompanying hirsutism and virilising features)</li><li>Pelvic ultrasound (in females to exclude polycystic ovaries if hirsutism present)</li></ul><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To improve cosmetic appearance</li><li>To prevent complications particularly scarring</li><li>To reassure patient</li><li>To identify and avoid any causative or contributing factors</li></ul><p>&nbsp;</p><p><strong>Non-pharmacological treatment</strong></p><ul><li>Counselling of patients</li></ul><p><strong>Pharmacological treatment</strong></p><p><strong>A. For mild to moderate acne</strong></p><p>Evidence Rating: [A]</p><ul><li>Benzoyl peroxide 5% lotion, topical, apply daily (avoiding mouth, eyes and the mucous membranes)</li></ul><p><strong>And</strong></p><ul><li>Clindamycin, 1% lotion or gel, topical, apply daily</li></ul><p><strong>Or</strong></p><ul><li>Tretinoin 0.01% gel, topical, apply nocte (avoiding the sun, eyes, nostrils, mouth, mucous membrane and broken skin)</li></ul><p><strong>Or</strong></p><ul><li>Adapalene 0.1% cream or gel, topical, apply thinly once daily (at night before sleep)</li></ul><p>&nbsp;</p><p><strong>B. For moderate to severe acne (or where topical therapy is&nbsp;ineffective or not tolerated)</strong></p><p>Evidence Rating: [B]</p><p>Topical treatment from above (A)</p><p><strong>And</strong></p><ul><li>Doxycycline, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>100 mg daily for 6 weeks-6 months (depending on response to treatment)</p><p><strong><u>Children</u></strong></p><p>Not recommended</p><p><strong>Or</strong></p><ul><li>Tetracycline, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>250-500 mg 12 hourly for 6 weeks-6 months (depending on response to treatment)</p><p>Change medication to erythromycin after 4 months if response is</p><p>poor</p><p><strong><u>Children</u></strong></p><p>&gt;12 years;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; same dose as for adults above</p><p>&lt; 12 years;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not recommended</p><p>&nbsp;</p><p><strong>Or</strong></p><ul><li>Erythromycin, oral,</li></ul><p><strong><u>Adult</u></strong></p><p>500 mg 12 hourly for 6 weeks-6 months</p><p><strong><u>Children</u></strong></p><p>&gt;12 years;&nbsp;&nbsp;500 mg 12 hourly for 6 weeks - 6 months</p><p>1-12 years;&nbsp; 125 mg 12 hourly</p><p>&nbsp;<strong>Or&nbsp;</strong></p><p>6 weeks-6 months&nbsp;; &nbsp;250 mg once daily for</p><p>&nbsp;</p><p><strong>REFERRAL CRITERIA</strong></p><p>Refer patients not responding to treatment to a dermatologist. Suspected underlying endocrine conditions should be referred to an endocrinologist.</p><p>&nbsp;</p>